Longitudinal follow-up of “benign” multiple sclerosis at 20 years
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To evaluate disease status after 20 years in a cohort defined as “benign multiple sclerosis (MS)” (Expanded Disability Status Scale [EDSS] score ≤ 3) at 10 years from onset.
Methods: Patients with an EDSS score ≤ 3 at 10 (± 1) years from onset were selected from the British Columbia MS clinic database. The 20-year EDSS score was the primary outcome. Potential risk factors differentiating those who “continued benign” (EDSS score ≤ 3.0) from those who were “no longer benign” (EDSS score > 3.0) at 20 years, including age at onset, onset symptoms, and 10-year EDSS score, were analyzed, and lower 10-year EDSS score cutoffs were investigated.
Results: Twenty-year EDSS scores were obtained for 169 of 200 patients (84.5%); of these, 88 (52.1%) continued benign, but 36 (21.3%) progressed to require the use of a cane (EDSS score ≥ 6). Conversion to secondary progressive MS occurred in 45 of 196 patients (23%) with a relapsing–remitting onset. The only variable associated with disease progression at 20 years was the 10-year EDSS score (p < 0.0005); no 10-year EDSS score seemed ideal in predicting benign status, and an EDSS score ≤ 2 resulted in 32% becoming no longer benign.
Discussion: At 10 years from onset, neither an Expanded Disability Status Scale (EDSS) score ≤ 3 nor an EDSS score ≤ 2 adequately represented “benign multiple sclerosis (MS)” because an appreciable proportion of patients progressed in disease severity. Appropriate and reliable criteria to identify which patients with MS remain with mild disability over the long term have yet to be determined.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Longitudinal follow-up of "benign" multiple sclerosis at 20 years
- Maria Pia Amato, Department of Neurology, University of Florence, Viale Morgagni 85, 50134 Florence, Italymariapia.amato@unifi.it
- Nicola De Stefano, Department of Neurology, University of Siena (Italy)
Submitted April 24, 2007 - Reply from the Authors
- Helen L. Tremlett, University of British Columbia, Medicine (Neurology), Rm. S178, UBC Hospital, 2211 Wesbrook Mall, University of British Columbia,Vancouver, BC. V6T 2B5tremlett@interchange.ubc.ca
- Ana-Luiza Sayao and Virginia Devonshire
Submitted April 24, 2007
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
A reassessment of the plateauing relationship between T2 lesion load and disability in MSMaria Pia Sormani, Marco Rovaris, Giancarlo Comi et al.Neurology, September 30, 2009 -
Research Article
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple SclerosisA Real-world Case SeriesRichard S. Nicholas, Elijah E. Rhone, Alice Mariottini et al.Neurology, July 12, 2021 -
Articles
Responsiveness and predictive value of EDSS and MSFC in primary progressive MSJ. J. Kragt, A. J. Thompson, X. Montalban et al.Neurology, January 09, 2008 -
Articles
Cigarette smoking and progression in multiple sclerosisMarcus Koch, Annemarie van Harten, Maarten Uyttenboogaart et al.Neurology, October 08, 2007